Diagnostic significance of biomarkers content changes in the case of atherosclerotic involvement of branchiocephalic arteries among the patients with chronic cerebral ischemia

Authors

  • Аліна Вікторівна Демченко University clinic of Zaporizhian state medical university Academician Amosov str., 83, Zaporizhzhya, Ukraine, 69063, Ukraine https://orcid.org/0000-0003-2291-0876

DOI:

https://doi.org/10.15587/2519-4798.2016.84000

Keywords:

chronic cerebral ischemia, atherosclerotic plaque, glutathione system, nitrogen oxide, homocysteine

Abstract

Aim of the work – to establish the diagnostic value of biomarkers content at atherosclerotic involvement of brachiocephalic vessels for optimization of diagnostic arrangements in patients with chronic cerebral ischemia (CCI).

Material and methods of research. 355 patients with CCI (among them 230 women and 125 men, mean age - 55,30±7,91years) were examined using clinical-neuropsychological, biochemical, immune-enzyme and ultrasound methods of examination. Atherosclerotic plaques (AP) of brachiocephalic vessels are visualized in 155 (43,7 %) patients.

Results. According to the results of research, the reliably lower concentrations of cholesterol of lipoproteins of the high density, stable metabolites NO, catalases and increased contents of fibrinogen, homocysteine and ketodin nitrofenol hydrazones were established in the blood serum of patients with CCI at AP and also the essential changes in concentration of renewed glutathione in both plasma and hemolysate of erythrocytes and increase of activity of glutathione reductase in hemolysate of erythrocytes and glutathione peroxidase in the blood plasma were registered. The decrease of concentration of stable metabolites of nitrogen oxide at increase of AP number was established.

Conclusions. The correlations were revealed between AP and the content of spontaneous ketodin nitrofenol hydrazones, homocysteine, cholesterol of lipoproteins of the high density, triglycerides, stable metabolites NO, and also activity of glutathione peroxidase in the blood plasma that testifies to the joint participation of studied biomarkers in atherosclerotic involvement of brachiocephalic vessels

Author Biography

Аліна Вікторівна Демченко, University clinic of Zaporizhian state medical university Academician Amosov str., 83, Zaporizhzhya, Ukraine, 69063

PhD, assistant, associate director

Department of Family Medicine, Therapy and Cardiology of FPE 

References

  1. Berezin, A. E. (2015). Rol endotelialnoy disfunktsii v razivtii kardiovaskulyarnyih zabolevaniy: perspektivyi farmakologicheskoy korrektsii donatorami oksida azota [The role of endothelial dysfunction in cardiovascular disease: Prospects pharmacological correction of nitric oxide donators]. Ukrainskyi medychnyi chasopys, 5, 50–55.
  2. Belenichev, I. F., Cherniy, V. I., Nagornaya, E. A. et. al. (2015). Neyroprotektsiya i neyroplastichnost [Neuroprotection and neuroplasticity]. Кyiv: Logos, 510.
  3. Weissberg, P. L. (2000). Coronary disease: Atherogenesis: current understanding of the causes of atheroma. Heart, 83 (2), 247–252. doi: 10.1136/heart.83.2.247
  4. Chrissobolis, S., Miller, A. A., Drummond, G. R., Kemp-Harper, B. K., Sobey, C. G. (2011). Oxidative stress and endothelial dysfunction in cerebrovascular disease. Frontiers in Bioscience, 16 (1), 1733–1775. doi: 10.2741/3816
  5. Hirata, Y., Nagata, D., Suzuki, E., Nishimatsu, H., Suzuki, J., Nagai, R. (2010). Diagnosis and Treatment of Endothelial Dysfunction in Cardiovascular Disease. International Heart Journal, 51 (1), 1–6. doi: 10.1536/ihj.51.1
  6. Fedin, A. I., Staryih, E. P., Putilina, M. V., Staryih, E. V., Mironova, O. P., Badalyan, K. R. (2015). Endotelialnaya disfunktsiya u bolnyih s hronicheskoy ishemiey mozga i vozmozhnosti ee farmakologicheskoy korrektsii [Endothelial dysfunction in patients with chronic cerebral ischemia and the possibilities of its pharmacological correction]. Lechaschiy vrach, 5, 15–20.
  7. Tovazhnyanskaya, E. L., Bezuglova, I. O., Dubinskaya, O. I., Kauk, O. I., Reznichenko, E. K., Koryak, V. V. (2014). Endotelialnaya disfunktsiya i tserebrovaskulyarnaya patologiya u bolnyih saharnyim diabetom [Endothelial dysfunction and cerebrovascular pathology in patients with diabetes mellitus]. Mezhdunarodnyiy meditsinskiy zhurnal, 20 (3), 26–30.
  8. Filimonov, D. A. (2012). Gipergomotsisteinemiya kak prokoagulyantnyiy faktor riska u patsientov s aterotromboticheskim ishemicheskim insultom i vozmozhnosti lechebnoy korrektsii [Hyperhomocysteinemia as a procoagulant risk factor in patients with atherothrombotic ischemic stroke and the possibility of medical correction]. Neironauky: teoretychni ta klinichni aspekty, 2 (8), 204–208.
  9. Golovchenko, Yu. I., Treschinskaya, M. A. (2010). Obzor sovremennyih pred-stavleniy ob endotelialnoy disfunktsii [The review of modern concepts of endothelial dysfunction]. Сonsilium medicum Ukraina, 11, 38–39.
  10. Galano, A., Alvarez-Idaboy, J. R. (2011). Glutathione: mechanism and kinetics of its non-enzymatic defense action against free radicals. RSC Advances, 1 (9), 1763–1771. doi: 10.1039/c1ra00474c
  11. Wu, B., Dong, D. (2012). Human cytosolic glutathione transferases: structure, function, and drug discovery. Trends in Pharmacological Sciences, 33 (12), 656–668. doi: 10.1016/j.tips.2012.09.007
  12. Gorozhanskaya, E. G., Larionova, V. B., Zubrihina, G. N., Chimishkjan, K. L., Laktionov, K. P., Davydova, T. V., Kormosh, N. G. (2002). Soderzhanie glutationa i aktivnost glutation-S-transferazyi kak faktor prognoza effektivnosti lekarstvennoy terapii [Content of glutathione and activity of glutathione-S-transferaze as prognostic factors of the effectiveness medicine therapy]. Rossiyskiy onkologicheskiy zhurnal, 5, 29–32.
  13. Zanozina, O. V., Sorokina, Yu. A., Borovkov, N. N., Scherbatyuk, T. G. (2013). «Porochnyiy krug» vzaimosvyazi perekisnogo okisleniya lipidov i okislitelnoy modifikatsii belkov u bolnyih saharnyim diabetom 2-go tipa [«Vicious circle» of intercommunication peroxidation of lipids and oxidative modification of proteins for patients by the diabetes mellitus of 2th type]. Meditsinskiy almanah, 6 (30), 167–170.
  14. Mishchenko, L. A. (2012). Zv’iazok netradytsiinykh chynnykiv sertsevo-sudynnoho ryzyku z oznakamy aterosklerozu u khvorykh na hipertonichnu khvorobu [Interaction of non-traditional cardiovascular risk factors with signs of atherosclerotic artery damage in essential hypertensive patients]. Ukrainskyi kardiolohichnyi zhurnal, 2, 54–59.
  15. Evtushenko, S. K., Filimonov, D. A., Simonyan, V. A., Lutskiy, I. S., Shestova, E. P., Morozova, T. M. (2013). Osnovnyie i novyie faktoryi riska, sposobstvuyuschie razvitiyu ishemicheskih insultov u lits molodogo vozrasta [The main and new risk factors that contribute to the development of ischemic strokes in young adults]. Mezhdunarodnyiy nevrologicheskiy zhurnal, 6 (60), 92–100.
  16. Verlan, N. V., Barahovskaya, T. V., Kolesnichenko, L. S. (2010). Farmakologicheskaya korrektsiya meksidolom svobodno-radikalnyih protsessov u bolnyih distsirkulyatornoy entsefalopatiey [Pharmacological correction of free radical processes in patiens with discirculatory encephalopathy]. Vestnik Buryatskogo gosuniversiteta, 12, 11–14.
  17. Lemeshko, E. H., Kolesnichenko, L. S., Verlan, N. V., Gubina, L. P., Pensionerova, G. A., Sergeeva, M. P., Stanevich, L. M. et. al. (2010). Sistema glutationa i ee korrektsiya u bolnyih hronicheskoy ishemiey mozga i saharnyim diabetom vtorogo tipa legkoy i sredney stepeni tyazhesti [Glutathione system and its correction in patients with chronic ischemia of brain and diabetes melites of the second type of light and average degree of severity]. Sibirskiy meditsinskiy zhurnal, 96 (6), 72–74.
  18. Demchenko, A. V. (2016). Systema hlutationu plazmy krovi pry khronichnii ishemii mozku [Glutathione system in blood plasma in case of chronic cerebral ischemia]. Visnyk problem biolohii, 1 (131), 86–90.
  19. Demchenko, A. V. (2016). Stan systemy hlutationu u hemolizati erytrotsytiv khvorykh na khronichnu ishemiiu mozku [Glutathione system state in a hemolysate of erythrocytes among the patients with chronic cerebral ischemia]. Skhidno-Ievropeiskyi nevrolohichnyi zhurnal, 4 (10), 37–43.
  20. Chekman, I. S., Belenichev, I. F., Nagornaya, E. A. et. al. (2016). Doklinicheskoe izuchenie spetsificheskoy aktivnosti potentsialnyih lekarstvennyih sredstv pervichnoy i vtorichnoy neyroprotektsii [Preclinical study of the specific activity of potential drugs and secondary primary neuroprotection]. Kyiv: OOO «Izdatelstvo «Yuston», 82.
  21. Meng, R., Li, Z.-Y., Ji, X., Ding, Y., Meng, S., Wang, X. (2011). Antithrombin III associated with fibrinogen predicts the risk of cerebral ischemic stroke. Clinical Neurology and Neurosurgery, 113 (5), 380–386. doi: 10.1016/j.clineuro.2010.12.016
  22. Sreckovic, B., Sreckovic, V. D., Soldatovic, I., Colak, E., Sumarac-Dumanovic, M., Janeski, H. et. al. (2016). Homocysteine is a Marker for Metabolic syndrome and Atherosclerosis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. doi: 10.1016/j.dsx.2016.08.026
  23. Ravaieva, M. Iu., Chuian, O. M., Drevetniak, N. A. (2013). Rol oksydu azotu v rozvytku endotelialnoi dysfunktsii [The role of nitric oxide in endothelial dysfunction]. Vcheni zapysky Tavriiskoho natsionalnoho universytetu im. V. I. Vernadskoho. Seriia «Biolohiia, khimiia», 26 (4), 147–157.
  24. Yarkova, S. V. (2015). Rol markeriv prohresuvannia aterosklerozu ta endotelialnoi dysfunktsii v diahnostytsi khronichnoi ishemii mozku [A role of atherosclerosis advance and endothelial dysfunction markers in diagnostics of chronic cerebral ischemia]. Ukrainskyi nevrolohichnyi zhurnal, 2, 42–46.
  25. Kulinskiy, V. I., Kolesnichenko, L. S. (2009). Sistema glutationa 1. Sintez, transport glutationtransferazyi, glutationperoksidazyi [A glutathione system 1. Synthesis and transport of glutathionetransferase, glutathione peroxidase]. Biomedicinskaja himija, 55 (3), 255–277.
  26. Higashi, Y., Noma, K., Yoshizumi, M., Kihara, Y. (2009). Endothelial Function and Oxidative Stress in Cardiovascular Diseases. Circulation Journal, 73 (3), 411–418. doi: 10.1253/circj.cj-08-1102

Downloads

Published

2016-11-30

How to Cite

Демченко, А. В. (2016). Diagnostic significance of biomarkers content changes in the case of atherosclerotic involvement of branchiocephalic arteries among the patients with chronic cerebral ischemia. ScienceRise: Medical Science, (11 (7), 9–15. https://doi.org/10.15587/2519-4798.2016.84000

Issue

No. 11 (7) (2016)

Section

Medical Science

License

Copyright (c) 2016 Аліна Вікторівна Демченко

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.